Our humanized mucOne mAbs consist of distinct sequence families

all selectively targeting tumors while exhibiting diverse mucin-1 binding profiles

  • Sequence integrity

  • Affinity

  • Specificity

  • Developability

Our mucOne antibody sequences are in silico analyzed from deep sequencing data and validated for optimal tumor targeting, developability, and strong IP protection